Synthesis of Benzoindolines via a Copper-Catalyzed Reaction
13C NMR (100 MHz, CDCl3): d=21.6, 28.9, 34.0, 52.9, 111.2
2H), 4.27 (d, J=4.0 Hz, 2H), 5.06–5.12 (m, 2H), 6.06–6.09
(m, 1H), 7.27–7.32 (m, 4H), 7.46–7.54 (m, 4H), 8.06 (d, J=
8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=21.5, 28.8,
33.8, 52.9, 115.5, 121.6, 125.8, 127.2, 127.7, 127.8, 128.9,
129.4, 131.0, 133.2, 133.5, 135.4, 136.0, 137.8, 138.0, 138.6;
HR-MS (ESI): m/z=386.1163, calcd. for C22H21NO2S (M+
Na+): 386.1191.
9-Allyl-1-(4-bromophenylsulfonyl)-6-methyl-2,3-dihydro-
1H-benzo[f]indole (3j): yield: 65%; 1H NMR (400 MHz,
CDCl3): d=2.29 (t, J=6.8 Hz, 2H), 2.49 (s, 3H), 4.02 (t, J=
6.8 Hz, 2H), 4.24 (s, 2H), 5.06–5.10 (m, 2H), 6.04–6.07 (m,
1H), 7.24–7.32 (m, 4H), 7.43–7.48 (m, 3H), 8.05 (d, J=
8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=21.5, 28.9,
33.8, 52.9, 115.6, 121.8, 125.8, 127.3, 128.0, 128.4, 129.2,
129.5, 131.0, 132.2, 133.5, 135.6, 135.6, 136.9, 137.8, 138.3;
HR-MS (ESI): m/z=464.0275, calcd. for C22H20BrNO2S
(M+Na+): 464.0296.
9-Allyl-6-methyl-1-(methylsulfonyl)-2,3-dihydro-1H-ben-
zo[f]indole (3k): yield: 77%; 1H NMR (400 MHz, CDCl3):
d=2.48 (s, 3H), 2.78 (s, 3H), 3.17 (t, J=6.4 Hz, 2H), 4.09
(d, J=4.0 Hz, 2H), 4.14 (t, J=6.8 Hz, 2H), 5.01–5.04 (m,
2H), 5.95–5.99 (m, 1H), 7.29 (d, J=8.4 Hz, 1H), 7.52–7.53
(m, 2H), 7.98 (d, J=8.4 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d=21.4, 30.0, 33.5, 37.4, 53.3, 115.5, 122.2, 125.6,
127.2, 128.0, 128.9, 131.0, 133.5, 135.1, 135.5, 137.7, 138.2;
HR-MS (ESI): m/z=324.1039, calcd. for C17H19NO2S (M+
Na+): 324.1034.
9-Allyl-1-(diphenylphosphoryl)-6-methyl-2,3-dihydro-1H-
benzo[f]indole (3l): yield: 35%; 1H NMR (400 MHz,
CDCl3): d=2.43 (s, 3H), 2.84 (t, J=6.8 Hz, 2H), 3.66–3.72
(m, 2H), 3.80 (d, J=4.8 Hz, 2H), 4.73–4.80 (m, 2H), 5.58–
5.65 (m, 1H), 7.18 (d, J=8.4 Hz, 1H), 7.40–7.41 (m, 8H),
7.70–7.76 (m, 5H); 13C NMR (100 MHz, CDCl3): d=21.3,
30.6, 33.4, 53.0 (d, JP, C =3.8 Hz), 114.9, 121.5, 122.4, 124.9,
2
2
(d, JCF =20.1 Hz), 115.5 (d, JC,F =23.8 Hz), 115.7, 121.5 (d,
4JC,F =4.8 Hz), 127.7, 128.4 (d, 3JC,F =8.6 Hz), 129.6, 129.8,
134.2 (d, 3JC,F =8.6 Hz), 134.8, 137.6, 137.7, 139.1, 139.1,
144.3, 160.6 (d, 1JC,F =244.0 Hz); HR-MS (ESI): m/z=
404.1105, calcd. for C22H20FNO2S (M+Na+): 404.1096.
9-Allyl-7-fluoro-1-tosyl-2,3-dihydro-1H-benzo[f]indole
(3d): yield: 70%; 1H NMR (400 MHz, CDCl3): d=2.26 (t,
J=6.4 Hz, 2H), 2.36 (s, 3H), 4.00 (t, J=6.4 Hz, 2H), 4.21
(d, J=4.0 Hz, 2H), 5.08–5.12 (m, 2H), 6.03–6.06 (m, 1H),
7.11 (d, J=7.6 Hz, 2H), 7.17–7.21 (m, 1H), 7.34–7.36 (m,
3H), 7.65–7.68 (m, 1H), 7.78 (d, J=11.6 Hz, 1H); 13C NMR
2
(100 MHz, CDCl3): d=21.6, 28.8, 34.0, 52.9, 109.9 (d, JC,F
=
2
21.9 Hz), 115.7 (d, JC,F =24.8 Hz), 115.9, 122.1, 127.7, 128.9
(d, JC,F =5.7 Hz), 129.6, 130.1, 130.2 (d, JC,F =8.6 Hz), 134.1
4
3
3
4
(d, JC,F =8.7 Hz), 134.9, 135.5 (d, JC,F =1.9 Hz), 137.4, 140.5,
144.3, 160.6 (d, 1JC,F =243.1 Hz); HR-MS (ESI): m/z=
404.1115, calcd. for C22H20FNO2S (M+Na+): 404.1096.
9-Allyl-6-chloro-1-tosyl-2,3-dihydro-1H-benzo[f]indole
(3e): yield: 66%; 1H NMR (400 MHz, CDCl3): d=2.25 (t,
J=6.8 Hz, 2H), 2.36 (s, 3H), 4.00 (t, J=6.8 Hz, 2H), 4.24 (s,
2H), 5.04–5.07 (m, 2H), 6.00–6.04 (m, 1H), 7.10 (d, J=
7.2 Hz, 2H), 7.26 (s, 1H), 7.33 (d, J=7.2 Hz, 2H), 7.39 (d,
J=8.8 Hz, 1H), 7.65 (s, 1H), 8.08 (d, J=8.8 Hz, 1H);
13C NMR (100 MHz, CDCl3): d=21.6, 28.9, 33.8, 52.8, 115.8,
121.3, 126.3, 126.7, 127.6, 127.7, 129.6, 129.7, 131.2, 131.6,
134.0, 134.8, 137.6, 139.8, 144.4; HR-MS (ESI): m/z=
420.0779, calcd. for C22H20ClNO2S (M+Na+): 420.0801.
4-Allyl-5-tosyl-6,7-dihydro-5H-thieno
G
(3f):
yield: 30%; 1H NMR (400 MHz, CDCl3): d=2.19 (t, J=
6.4 Hz, 2H), 2.37 (s, 3H), 4.01 (t, J=6.4 Hz, 2H), 4.13 (d,
J=5.2 Hz, 2H), 5.08–5.12 (m, 2H), 6.05–6.09 (m, 1H), 7.12
(d, J=7.2 Hz, 2H), 7.34–7.41 (m, 4H), 7.53 (d, J=5.2 Hz,
1H); 13C NMR (100 MHz, CDCl3): d=21.6, 29.0, 35.3, 53.3,
115.7, 116.4, 123.5, 126.0, 127.8, 128.9, 129.5, 134.7, 135.1,
137.4, 138.5, 138.9, 139.7, 144.1; HR-MS (ESI): m/z=
392.0730, calcd. for C20H19NO2S2 (M+Na+): 392.0755.
127.0, 127.4, 128.6 (d, JP, C =12.4 Hz), 131.0, 132.1 (d, JP, C
125.8 Hz), 132.2 (d, JP, C =22.8 Hz), 132.2, 133.7, 135.7 (d,
P, C =3.8 Hz), 137.3, 141.8; 31P NMR (100 MHz, CDCl3): d=
=
J
9-(But-3-en-2-yl)-6-methyl-1-tosyl-2,3-dihydro-1H-benzo-
[f]indole (3g): yield: 60%; H NMR (400 MHz, CDCl3): d=
28.7; HR-MS (ESI): m/z=446.1661, calcd for C28H26NOP
1
(M+Na+): 446.1650.
1.65 (d, J=6.8 Hz, 3H), 2.14–2.32 (m, 2H), 2.36 (s, 3H),
2.47 (s, 3H), 3.94–4.06 (m, 2H), 4.91 (s, 1H), 5.21–5.28 (m,
2H), 6.47–6.54 (m, 1H), 7.10 (d, J=7.2 Hz, 2H), 7.23–7.26
(m, 2H), 7.36 (d, J=7.2 Hz, 2H), 7.46 (s, 1H), 8.29 (d, J=
8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=18.7, 21.4,
21.7, 29.0, 37.9, 53.0, 112.8, 121.8, 127.0, 127.0, 127.5, 127.8,
129.5, 130.2, 134.2, 135.0, 135.0, 135.1, 136.1, 138.5, 144.0,
144.1; HR-MS (ESI): m/z=414.1474, calcd. for C24H25NO2S
(M+Na+): 414.1504.
7-Fluoro-9-(1-phenylallyl)-1-tosyl-2,3-dihydro-1H-benzo-
[f]indole (3m): yield: 65%; H NMR (400 MHz, CDCl3): d=
1
2.26–2.30 (m, 2H), 2.39 (s, 3H), 4.00–4.13 (m, 2H), 5.25–
5.27 (m, 2H), 6.24 (d, J=6.4 Hz, 1H), 6.52–6.56 (m, 1H),
7.10–7.20 (m, 4H), 7.26–7.29 (m, 2H), 7.34–7.35 (m, 2H),
7.42–7.46 (m, 4H), 7.63–7.67 (m, 1H); 13C NMR (100 MHz,
CDCl3): d=21.7, 29.1, 50.0, 53.2, 112.1 (d, 2JC,F =22.9 Hz),
115.7 (d, 2JC,F =24.7 Hz), 118.0, 123.0, 126.1, 127.8, 128.1,
3
4
128.2, 129.7, 130.3 (d, JC,F =9.5 Hz), 130.9, 132.0 (d, JC,F
=
=
4
6-Methyl-9-(1-phenylallyl)-1-tosyl-2,3-dihydro-1H-benzo-
5.7 Hz), 132.7(d, 3JC,F=9.6 Hz), 135.1, 135.7 (d, JC,F
1.9 Hz), 138.9, 141.7, 142.2, 144.4, 159.7 (d, JC,F =243.1 Hz);
HR-MS (ESI): m/z=480.1427, calcd. for C28H24FNO2S (M+
Na+): 480.1409.
1
1
[f]indole (3h): yield: 75%; H NMR (400 MHz, CDCl3): d=
2.21–2.35 (m, 2H), 2.39 (s, 3H), 2.42 (s, 3H), 3.98–4.16 (m,
2H), 5.25–5.34 (m, 2H), 6.26 (d, J=7.2 Hz, 1H), 6.53–6.60
(m, 1H), 7.06 (d, J=8.4 Hz, 1H), 7.11–7.21 (m, 3H), 7.23–
7.30 (m, 2H), 7.36–7.40 (m, 3H), 7.43–7.50 (m, 3H), 7.71 (d,
J=8.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=21.4, 21.7,
29.2, 50.2, 53.2, 117.7, 122.5, 125.8, 127.1, 127.5, 127.8, 127.9,
128.1, 128.2, 129.6, 129.7, 132.4, 134.3, 135.1, 135.2, 136.4,
139.6, 140.0, 143.0, 144.2; HR-MS (ESI): m/z=476.1663,
calcd. for C29H27NO2S (M + Na+): 476.1660.
4-(1-Phenylallyl)-5-tosyl-6,7-dihydro-5H-thienoACTHNUGTRNEUNG[2,3-f]-
indole (3n): yield: 55%; 1H NMR (400 MHz, CDCl3): d=
2.18–2.29 (m, 2H), 2.39 (s, 3H), 4.01–4.11 (m, 2H), 5.24–
5.30 (m, 2H), 6.14 (d, J=6.8 Hz, 1H), 6.35–6.42 (m, 1H),
7.01 (d, J=4.8 Hz, 1H), 7.16–7.20 (m, 4H), 7.26–7.29 (m,
2H), 7.36 (d, J=7.2 Hz, 2H), 7.43–7.45 (m, 3H); 13C NMR
(100 MHz, CDCl3): d=21.7, 29.2, 50.2, 53.5, 117.1, 117.5,
125.0, 125.5, 126.0, 127.9, 128.0, 128.4, 129.6, 132.3, 134.8,
135.3, 138.3, 139.1, 139.3, 140.0, 142.5, 144.2; HR-MS (ESI):
m/z=468.1042, calcd. for C26H23NO2S2 (M+Na+): 468.1068.
9-Allyl-6-methyl-1-(phenylsulfonyl)-2,3-dihydro-1H-ben-
zo[f]indole (3i): yield: 68%; 1H NMR (400 MHz, CDCl3):
d=2.21 (t, J=6.8 Hz, 2H), 2.48 (s, 3H), 4.02 (t, J=6.8 Hz,
Adv. Synth. Catal. 2012, 354, 3087 – 3094
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3091